http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113552357-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2d422b9357e5be60f36faf00a3ae5be |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-914 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2021-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f962a544989b36c20a134460c5c82df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dc9a82edd377f2d570dd9474cefb9bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cece3e100b1f0c7e0fcb888fff213720 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27ce7f56acdfb3e97597f3859b933573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3e94655481d55873159a7b3ecb87ed1 |
| publicationDate | 2021-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113552357-A |
| titleOfInvention | Application of leukotriene A4 hydrolase as an early marker of lung cancer |
| abstract | The invention provides the application of a leukotriene A4 hydrolase as an early marker of lung cancer, and belongs to the technical field of laboratory medicine. The invention provides the application of a leukotriene A4 hydrolase as a marker in preparing a product for evaluating the risk of lung cancer. The present invention finds that the expression level of leukotriene A4 hydrolase in lung cancer serum is higher than that in normal serum, which can be used as a marker for lung cancer diagnosis, and can be used for auxiliary diagnosis of lung cancer, targeted therapy, or the occurrence and development of lung cancer disease. , process-related basic research, etc. The method of the invention is simple, rapid and sensitive, is suitable for auxiliary diagnosis of preclinical lung cancer and biologically guided treatment of tumors, and has wide clinical application prospects and basic application prospects. |
| priorityDate | 2021-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 359.